Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhao, Lei ^a   Zhong, Shan ^a   Qu, Haiyang ^a   Xie, Yunxia ^a   Cao, Zhennan ^a   Li, Qing ^a   Yang, Ping ^a   Varghese, Zac ^b   Moorhead, John F ^b   Chen, Yaxi ^a   Ruan, Xiong Z ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; CYTOKINE; FATTY ACID;

ANIMAL; BIOSYNTHESIS; BLOOD; BODY MASS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; ENDOPLASMIC RETICULUM STRESS; IMMUNOLOGY; INFLAMMATION; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BODY MASS INDEX; CASEINS; CELLS, CULTURED; CYTOKINES; DIET, HIGH-FAT; ENDOPLASMIC RETICULUM STRESS; FATTY ACIDS; INFLAMMATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84929379863     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10222     Document Type: Article

References (42)

1. Browning, J.D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395 (2004).
2. Gholam, P.M., Kotler, D.P. & Flancbaum, L.J. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes. Surg. 12, 49-51 (2002).
3. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
4. Haukeland, J.W. et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J. Hepatol. 44, 1167-1174 (2006).
5. Targher, G. et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity. (Silver. Spring) 16, 1394-1399 (2008).
6. Kolak, M. et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56, 1960-1968 (2007).
7. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. & Spiegelman, B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415 (1995).
8. McAdam, K.P. & Sipe, J.D. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J. Exp. Med. 144, 1121-1127 (1976).
9. Gabele, E. et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J. Hepatol. 55, 1391-1399 (2011).
10. Zhang, H. et al. Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain. Neuroscience 157, 895-907 (2008).
11. Herman Hernandes, C.E., Scheinberg, M.A., Benson, M.D. & Finkelstein, A.E. The effect of gold salts on casein-induced macrophage activation and serum amyloid protein SAA levels. Clin. Exp. Rheumatol. 4, 347-350 (1986).
12. Ma, K. L. et al. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology 48, 770-781 (2008).
13. Wal, J. M. Cow's milk proteins/allergens. Ann. Allergy. Asthma. Immunol. 89, 3-10 (2002).
14. Miura, K., Takahashi, Y. & Shirasawa, H. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection. Lab. Invest. 53, 453-463 (1985).
15. Wu, Y. et al. Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet. J. Endocrinol. 219, 195-204 (2013).
16. Ndumele, C. E. et al. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 1927-1932 (2011).
17. Wouters, K. et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48, 474-486 (2008).
18. Tetri, L.H., Basaranoglu, M., Brunt, E.M., Yerian, L.M. & Neuschwander-Tetri, B.A. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am. J. Physiol: Gastrointest. Liver. Physiol. 295, G987-995 (2008).
19. Barreyro, F.J. et al. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver. Int. doi:10.1111/liv.12570 (2014).
20. Liu, Y. et al. Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice. PloS one 7, e39165 (2012).
21. Williamson, R.M. et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 34, 1139-1144 (2011).
22. Byrne, C.D. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc. Nutr. Soc. 1-8 (2013).
23. Day, C.P. & James, O.F. Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845 (1998).
24. Miele, L. et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877-1887 (2009).
25. Ruan, X.Z., Varghese, Z. & Moorhead, J.F. An update on the lipid nephrotoxicity hypothesis. Nat. Rev. Nephrol. 5, 713-721 (2009).
26. Tilg, H. & Moschen, A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846 (2010).
27. Chen, Y. et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. J. Gastroenterol. Hepatol. 27, 974-984 (2012).
28. Cani, P.D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007).
29. Kohjima, M. et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 20, 351-358 (2007).
30. Moylan, C.A. et al. Hepatic gene expression profiles differentiate pre-symptomatic patients with mild versus severe nonalcoholic fatty liver disease (Severe NAFLD Gene Signature). Hepatology 59, 471-482 (2014).
31. Donnelly, K.L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351 (2005).
32. Rector, R.S. et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J. Hepatol. 52, 727-736 (2010).
33. Zhang, D. et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc. Natl. Acad. Sci. USA 104, 17075-17080 (2007).
34. Stefanovic-Racic, M. et al. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol: Endocrinol. Metab. 294, E969-E977 (2008).
35. Morgan, M.J. & Liu, Z.G. Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol. Cells 30, 1-12 (2010).
36. Kolattukudy, P.E. & Niu, J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ. Res. 110, 174-189 (2012).
37. Shao, M. et al. Hepatic IRE1alpha regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARalpha axis signalling. Nat. Commun. 5, 3528 (2014).
38. Hotamisligil, G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917 (2010).
39. Maurizio, P. & Novo, E. Nrf1 gene expression in the liver: a single gene linking oxidative stress to NAFLD, NASH and hepatic tumours. J. Hepatol. 43, 1096-1097 (2005).
40. Todd, D.J., Lee, A.H. & Glimcher, L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol. 8, 663-674 (2008).
41. Kuhajda, F.P. et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl. Acad. Sci. USA 97, 3450-3454 (2000).
42. Karlic, H., Lohninger, S., Koeck, T. & Lohninger, A. Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J. Histochem. Cytochem. 50, 205-212 (2002).